Share This Article:

Dosimetric Impact of Tumor Position and Lung Density Variations in Lung Stereotactic Body Radiotherapy

Abstract Full-Text HTML XML Download Download as PDF (Size:841KB) PP. 43-48
DOI: 10.4236/ijmpcero.2014.31007    3,376 Downloads   6,977 Views   Citations

ABSTRACT

Purpose of this study was to evaluate the variation of the dose to gross tumor volume (GTV) related to tumor position and lung density for lung stereotactic body radiotherapy (SBRT) using a virtual phantom. The density of the equivalent lung surrounding the GTV (10 mm diameter) was defined as 0.10, 0.15, 0.25, 0.35, and 0.45 g/cm3. A planning target volume (PTV) was generated by adding a uniform 8 mm margin to the internal target volume (ITV). We defined that the 99% of the GTV should be covered by 100% of the prescribed dose using Monte Carlo (MC) calculation. The GTV structure was replicated from ITV to the PTV periphery at 1 mm intervals. Planned dose to the GTV was defined as the predicted dose in the replicated GTV structure. Simulated dose to the GTV was defined as the calculated dose in the replicated GTV structure taking into account the tumor position error. D99 of the planned dose to the GTV at the 8 mm shift position was 78.1%, 81.6%, 87.3%, 91.4% and 94.4% at equivalent lung densities of 0.10, 0.15, 0.25, 0.35, and 0.45 g/cm3, respectively. D99 of the simulated dose to the GTV at the 8 mm shift position was 96.9%, 95.3%, 94.2%, 95.1 % and 96.3% at equivalent lung densities of 0.10, 0.15, 0.25, 0.35, and 0.45 g/cm3, respectively. Planned dose to GTV is strongly dependent on lung density and tumor position errors, while simulated dose to GTV does not show any significant dependence.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

H. Miura, N. Masai, R. Oh, H. Shiomi, K. Yamada, M. Usmani and T. Inoue, "Dosimetric Impact of Tumor Position and Lung Density Variations in Lung Stereotactic Body Radiotherapy," International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, Vol. 3 No. 1, 2014, pp. 43-48. doi: 10.4236/ijmpcero.2014.31007.

References

[1] Y. Nagata, J. Wulf, I. Lax, et al., “Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy Agency,” International Journal of Radiation Oncology* Biology*Physics, Vol. 79, No. 3, 2011, pp. 660-669.
[2] H. Onishi, T. Araki, H. Shirato, et al., “Stereotactic Hypofractionated High-Dose Irradiation for Stage I Non-Small Cell Lung Carcinoma,” Cancer, Vol. 101, No. 7, 2004, pp. 1623-1631.
http://dx.doi.org/10.1002/cncr.20539
[3] Y. Nagata, K. Takayama, Y. Matsuo, et al., “Clinical Outcomes of a Phase I/II Study of 48 Gy of Stereotactic Body Radiotherapy in 4 Fractions for Primary Lung Cancer Using a Stereotactic Body Frame,” International Journal of Radiation Oncology*Biology*Physics, Vol. 63, No. 5, 2005, pp. 1427-1431.
[4] L. R. Aarup, A. E. Nahum, C. Zacharatou, et al., “The Effect of Different Lung Densities on the Accuracy of Various Radiotherapy Dose Calculation Methods: Implications for Tumour Coverage,” Radiotherapy & Oncology, Vol. 91, No. 3, 2009, pp. 405-414.
http://dx.doi.org/10.1016/j.radonc.2009.01.008
[5] G. X. Ding, D. M. Duggan, B. Lu , et al., “Impact of Inhomogeneity Corrections on Dose Coverage in the Treatment of Lung Cancer Using Stereotactic Body Radiation Therapy,” Medical Physics, Vol. 34, No. 7, 2007, pp. 2985-2994. http://dx.doi.org/10.1118/1.2745923
[6] N. C. van der Voort van Zyp, M. S. Hoogeman, S. van de Water, et al., “Clinical Introduction of Monte Carlo Treatment Planning: A Different Prescription Dose for Non-Small Cell Lung Cancer according to Tumor Location and Size,” Radiotherapy & Oncology, Vol. 96, No. 1, 2010, pp. 55-60.
http://dx.doi.org/10.1016/j.radonc.2010.04.009
[7] H. Miura, N. Masai, R. Oh, et al., “Clinical Introduction of Monte Carlo Treatment Planning for Lung Stereotactic Body Radiotherapy,” Journal of Applied Clinical Medical Physics, Vol. 15, No. 1, 2014, pp. 38-48.
[8] M. Guckenberger, J. Wilbert, T. Krieger, et al., “Four-Dimensional Treatment Planning for Stereotactic Body Radiotherapy,” International Journal of Radiation Oncology*Biology*Physics, Vol. 69, No. 1, 2007, pp. 276-285.
[9] P. Baumann, J. Nyman, M. Hoyer, et al., “Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy,” Journal of Clinical Oncology, Vol. 27, No. 20, 2009, pp. 3290-3296.
http://dx.doi.org/10.1200/JCO.2008.21.5681
[10] S. W. Lee, E. K. Choi, H. J. Park, et al., “Stereotactic Body Frame Based Fractionated Radiosurgery on Consecutive Days for Primary or Metastatic Tumors in the Lung,” Lung Cancer, Vol. 40, No. 3, 2003, pp. 309-315.
http://dx.doi.org/10.1016/S0169-5002(03)00040-0
[11] H. Miura, N. Masai, R. J. Oh, H. Shiomi, J. Sasaki and T. Inoue, “Approach to Dose Prescription of the Gross Tumor Volume for Lung Cancer with Respiratory Tumor Motion,” Journal of Radiation Research, Vol. 54, No. 1, 2013, pp. 140-145. http://dx.doi.org/10.1093/jrr/rrs054
[12] A. E. Nahum and B. Sanchez-Nieto, “Tumour Control Probability Modelling: Basic Principles and Applications in Treatment Planning,” Physica Medica, Vol. 17, No. S2, 2001, pp. 13-23.
[13] ESTRO Booklet No. 7, “Quality Assurance of Treatment Planning Systems,” Practical Examples for Non-IMRT Photon Beams, 2004.
http://estro-education.org/publications/Documents/Booklet_n7-QAorTPS.pdf
[14] M. Fippel, “Fast Monte Carlo Dose Calculation for Photon Beams Based on the VMC Electron Algorithm,” Medical Physics, Vol. 26, No. 8, 1999, pp. 1466-1475.
http://dx.doi.org/10.1118/1.598676
[15] M. Fippel, F. Haryanto, O. Dohm, F. Nüsslin and S. Kriesen, “A Virtual Photon Energy Fluence Model for Monte Carlo Dose Calculation,” Medical Physics, Vol. 30, No. 3, 2003, pp. 301-311.
http://dx.doi.org/10.1118/1.1543152
[16] M. Fippel, “Efficient Particle Transport Simulation through Beam Modulating Devices for Monte Carlo Treatment Planning,” Medical Physics, Vol. 31, No. 5, 2004, pp. 1235-1242. http://dx.doi.org/10.1118/1.1710734
[17] I. Kawrakow, M. Fippel and K. Friedrich, “3D Electron Dose Calculation Using a Voxel Based Monte Carlo Algorithm (VMC),” Medical Physics, Vol. 23, No. 4, 1996, pp. 445-457. http://dx.doi.org/10.1118/1.597673
[18] Task Group No. 65, the Radiation Therapy Committee of the American Association of Physicists in Medicine, “Tissue Inhomogeneity Corrections for Megavoltage Photon Beams,” Medical Physics Publishing, Madison, 2004.
[19] M. Nakamura, Y. Miyabe, Y. Matsuo, et al., “Experimental Validation of Heterogeneity-Corrected Dose-Volume Prescription on Respiratory-Averaged CT Images in Stereotactic Body Radiotherapy for Moving Tumors,” Medical Dosimetry, Vol. 37, No. 1, 2012, pp. 20-25.
http://dx.doi.org/10.1016/j.meddos.2010.12.007
[20] T. Krieger and Q. A. Sauer, “Monte Carlo-Versus Pencil-Beam-/Collapsed-Cone-Dose Calculation in a Heterogeneous Multilayer Phantom,” Physics & Medicine in Biology, Vol. 50, No. 5, 2005, pp. 859-868.
http://dx.doi.org/10.1088/0031-9155/50/5/010
[21] Z. Wang, J. W. Nelson, S. Yoo, et al., “Refinement of Treatment Setup and Target Localization Accuracy Using Three-Dimensional Cone-Beam Computed Tomography for Stereotactic Body Radiotherapy,” International Journal of Radiation Oncology*Biology*Physics, Vol. 73, No. 2, 2009, pp. 571-577.
[22] ICRU, “Prescribing, Recording, and Reporting Photon Beam Therapy,” ICRU Report Volume 50, International Commission on Radiation Units and Measurements, Bethesda, 1993.
[23] H. Miura, N. Masai, R. J. Oh, et al., “Dosimetric Comparison of Different Prescription Modes in Lung Stereotactic Body Radiation Therapy,” International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. (In Press)
[24] V. Gregoire, T. R. Mackie, W. D. Neve, et al., “Prescribing Recording and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT),” Journal of the ICRU, Vol. 10, No. 1, 2010, pp. 1-112.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.